Clinical Trials Browser

Phase 2 × Neoplasms × litronesib × Clear all

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Phase 2 Completed

39 enrolled 16 charts

Breast Neoplasms, Neoplasms, Recurrence